🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.
UPGRADE TO SEE LIVE SIGNALS
$DBV.PA
DBV Technologies
FREE PREVIEW
📅 Next Earnings: Jul 29, 2026 🌙 Close🌐 Website🏛️ Euronext Paris📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP0.69%
MAX GAP RECORD4.04%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY2.0%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk,… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL